Please login to the form below

Not currently logged in
Email:
Password:

shingles

This page shows the latest shingles news and features for those working in and with pharma, biotech and healthcare.

Gilead’s triple HIV drug approval prompts GSK lawsuit

Gilead’s triple HIV drug approval prompts GSK lawsuit

Biktarvy’s approval is a clear threat to ViiV and parent GSK, which is relying on Tivicay, Triumeq and Juluca to perform well - along with other new products such as shingles

Latest news

More from news
Approximately 11 fully matching, plus 31 partially matching documents found.

Latest Intelligence

  • Pharma deals in September 2015 Pharma deals in September 2015

    In a similar, but more complex financing deal transaction, Agenus is selling future royalties on a GlaxoSmithKline (GSK)-partnered vaccine adjuvant, QS-21, used alongside malaria and shingles vaccines, in exchange ... Licence. 126. Agenus. GlaxoSmithKline

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics